首页 / 院系成果 / 成果详情页

Chitosan Oligosaccharides Show Protective Effects in Coronary Heart Disease by Improving Antioxidant Capacity via the Increase in Intestinal Probiotics  期刊论文  

  • 编号:
    257a310a-a754-43a4-86de-687e8d13dee3
  • 作者:
  • 语种:
    英文
  • 期刊:
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY ISSN:1942-0900 2019 年 2019 卷
  • 收录:
  • 摘要:

    We explored the effects of chitosan oligosaccharides (COS) on coronary heart disease (CHD) patients. The component of COS was measured by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). CHD patients were evenly assigned into the COS group (COG) and the placebo group (CG). The duration of treatment was 6 months and therapeutic results were explored by measuring left ventricular ejection fraction (LVEF) value, Lee scores, quality of life (QOL), blood urea nitrogen, and serum creatinine. The intestinal flora were determined by 16s rDNA sequencing. The circulating antioxidant levels and lipid profiles were compared between two groups. There were 7 different degrees of polymerization (DP4-10) in COS. Lee scores, QOL scores, and LVEF values in the COG group were higher than those in the CG group (P < 0.05). COS treatment improved blood urea nitrogen and serum creatinine when compared with controls (P < 0.05). Circulating antioxidant levels were higher in the COG group than in the CG group. COS consumption increased the serum levels of SOD and GSH and reduced the levels of ALT and AST (P < 0.05). Meanwhile, lipid profiles were improved in the COG group. COS consumption increased the abundance of Faecalibacterium, Alistipes, and Escherichia and decreased the abundance of Bacteroides, Megasphaera, Roseburia, Prevotella, and Bifidobacterium (P < 0.05). On the other hand, COS consumption increased the probiotic species Lactobacillus, Lactococcus, and Phascolarctobacterium. The increased species have been reported to be associated with antioxidant properties or lipid improvement. COS had similar effects with chitohexaose on the growth rate of these species. Therefore, COS ameliorate the symptoms of CHD patients by improving antioxidant capacities and lipid profiles via the increase of probiotics in the intestinal flora.

  • 推荐引用方式
    GB/T 7714:
    Jiang Tiechao,Xing Xiaohong,Zhang Lirong, et al. Chitosan Oligosaccharides Show Protective Effects in Coronary Heart Disease by Improving Antioxidant Capacity via the Increase in Intestinal Probiotics [J].OXIDATIVE MEDICINE AND CELLULAR LONGEVITY,2019,2019.
  • APA:
    Jiang Tiechao,Xing Xiaohong,Zhang Lirong,Liu Zhen,&Liu Xin.(2019).Chitosan Oligosaccharides Show Protective Effects in Coronary Heart Disease by Improving Antioxidant Capacity via the Increase in Intestinal Probiotics .OXIDATIVE MEDICINE AND CELLULAR LONGEVITY,2019.
  • MLA:
    Jiang Tiechao, et al. "Chitosan Oligosaccharides Show Protective Effects in Coronary Heart Disease by Improving Antioxidant Capacity via the Increase in Intestinal Probiotics" .OXIDATIVE MEDICINE AND CELLULAR LONGEVITY 2019(2019).
  • 条目包含文件:
    文件类型:PDF,文件大小:
    正在加载全文
浏览次数:38 下载次数:0
浏览次数:38
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部